title: Could daratumumab be used to treat severe allergy?
authors.affiliation: Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: m.a.blankestijn@umcutrecht.nl.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Blankestijn
authors.affiliation: Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: Niels W C J
authors.initials: NWCJ
authors.lastname: van de Donk
authors.affiliation: Janssen Research & Development, Spring House, Pa.
authors.forename: Kate
authors.initials: K
authors.lastname: Sasser
authors.affiliation: Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: André C
authors.initials: AC
authors.lastname: Knulst
authors.affiliation: Department of Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: Henny G
authors.initials: HG
authors.lastname: Otten
mesh_terms: D051997:ADP-ribosyl Cyclase 1 / Q000276:immunology; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D039741:Antigens, Dermatophagoides / Q000276:immunology; D029662:Betula / Q000276:immunology; D017277:Drug Approval; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000628:therapy*; D007073:Immunoglobulin E / Q000097:blood; D007167:Immunotherapy / Q000379:methods*; D009101:Multiple Myeloma / Q000276:immunology / Q000628:therapy*; D009426:Netherlands; D010950:Plasma Cells / Q000187:drug effects / Q000276:immunology*; D011058:Pollen / Q000276:immunology; D039981:Pyroglyphidae / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D039741:Antigens, Dermatophagoides; D007073:Immunoglobulin E; C556306:daratumumab; D051997:ADP-ribosyl Cyclase 1